Home Data Calendar Blog

SDGR

Tables

    2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31
Weighted Average Number Of Diluted Shares Outstanding 72.7172.29NA71.9275.0673.82NA71.2171.1671.05NA70.7870.58NANA72.69NANANA44.88NANA
Weighted Average Number Of Shares Outstanding Basic 72.7172.29NA71.9271.6471.47NA71.2171.1671.05NA70.7870.58NANA66.34NANANA44.88NANA
Earnings Per Share Basic -0.74-0.76-0.43-0.860.061.81-0.39-0.56-0.67-0.48-0.43-0.49-0.49NA-0.180.06NANANA-0.26NANA
Earnings Per Share Diluted -0.74-0.76-0.41-0.860.061.75-0.39-0.56-0.67-0.48-0.43-0.49-0.49NA-0.180.05NANANA-0.26NANA

    2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31
Revenue From Contract With Customer Excluding Assessed Tax 47.3336.6074.1342.5735.1964.7856.8436.9838.4748.6646.1729.8529.7832.1333.0325.8023.0926.1725.8319.9619.0120.74
Revenues 47.3336.6074.1342.5735.1964.7856.8436.9838.4748.6646.1729.8529.7832.1333.0325.8023.0926.1725.8319.9619.0120.74
Cost Of Revenue 16.0017.7116.5818.9321.3819.0918.1419.7821.3420.6819.8118.7317.8015.9614.0410.539.5110.5510.309.259.167.74
Gross Profit 31.3418.8957.5523.6413.8145.6938.7017.2017.1327.9826.3611.1211.9816.1618.9915.2713.5815.6215.5310.719.8513.00
Operating Expenses 84.0686.3287.1779.8374.9476.1967.2463.3660.6156.6348.8845.7942.3240.0835.5830.7230.6727.4323.3722.0023.8118.62
Research And Development Expense 50.8450.6151.4946.8342.7040.7434.5432.8831.1227.8225.1423.2221.0921.4517.3217.0216.6613.7011.0810.359.538.44
General And Administrative Expense 23.5425.5425.7323.8923.2226.3123.3223.3222.0622.1317.7617.0115.8513.3913.589.739.658.946.556.468.945.09
Selling And Marketing Expense 9.6910.179.959.119.029.149.387.167.436.675.975.565.385.244.673.974.364.795.745.185.345.09
Operating Income Loss -52.73-67.43-29.62-56.19-61.13-30.50-28.54-46.16-43.47-28.64-22.52-34.67-30.34-23.91-16.58-15.45-17.09-11.80-7.85-11.29-13.96-5.61
Allocated Share Based Compensation Expense 12.8112.2212.5312.6511.7710.8810.219.8610.439.137.467.657.024.373.003.042.731.770.580.560.530.52
Income Tax Expense Benefit 0.080.46-0.84-2.89-20.4326.36-0.140.190.03-0.030.27-0.000.070.070.23-0.040.060.09-0.03-0.26-0.050.05
Income Taxes Paid Net 0.260.180.631.280.830.090.330.290.130.040.210.010.100.120.160.080.090.060.050.05-0.020.06
Profit Loss -54.05-54.72-30.67-62.024.28129.14-27.21-39.86-47.67-34.45-30.71-35.01-34.97-0.52-11.593.29-4.07-14.27-7.14-11.96-0.73-5.85
Net Income Loss -54.05-54.72-30.67-62.024.28129.14-27.21-39.85-47.69-34.44-30.71-35.01-34.64-0.03-11.143.85-3.35-13.83-6.77-11.51-0.50-5.79
Comprehensive Income Net Of Tax -54.16-55.08-29.90-61.834.49130.62-25.90-40.14-48.43-36.45-31.41-35.04-34.65-0.27-11.303.60-2.18-14.28-6.78-11.50-0.48-5.78

    2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31
Assets 688.37737.76802.96794.15841.57838.77688.59661.99687.88719.54756.49NA717.33744.19746.26680.12349.55349.87155.27NANANA
Liabilities 214.39224.06254.40230.57230.34248.51240.68198.86194.81188.87199.40NA111.56112.41122.2449.2353.4054.3257.01NANANA
Liabilities And Stockholders Equity 688.37737.76802.96794.15841.57838.77688.59661.99687.88719.54756.49NA717.33744.19746.26680.12349.55349.87155.27NANANA
Stockholders Equity 473.98513.71548.56563.58611.23590.26447.89463.11493.06530.67557.07NA605.75631.77624.01630.88296.12295.52-93.36NANANA

    2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31
Assets Current 449.18493.69567.80547.76591.96603.73533.99524.20556.87586.17625.06NA649.79675.24682.98621.11307.01312.81118.54NANANA
Cash And Cash Equivalents At Carrying Value 108.11130.24155.31249.38285.96233.2190.47102.82127.32117.26120.27NA117.70133.12202.30210.49110.38144.7525.99NANANA
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 112.34134.87161.07255.61291.02237.6995.72108.62130.82120.76123.27163.88120.70133.62202.80210.99110.88145.2526.4933.0944.4562.18
Marketable Securities Current 269.18300.84307.69246.91262.71294.48360.61370.74382.25408.27456.21NA495.89515.37440.39388.49173.65143.5059.84NANANA
Accounts Receivable Net Current 11.8519.8465.9919.889.6546.6955.9523.5818.7729.3231.74NA21.3611.2731.4212.2913.8516.2718.68NANANA

    2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment NANA18.15NANANA14.11NANANA12.36NANANA13.80NANANA10.56NANANA
Other Assets Noncurrent 3.603.196.017.415.076.233.312.881.801.332.85NA3.382.362.352.212.102.172.34NANANA

    2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31
Liabilities Current 99.76106.51133.67105.04106.80123.41108.8088.8285.5985.5391.21NA70.3867.6273.2039.2843.0542.1745.02NANANA
Accounts Payable Current 8.129.9716.8210.3212.4311.999.4710.925.269.778.08NA5.967.228.404.815.526.673.52NANANA
Other Accrued Liabilities Current 9.7210.5612.008.547.328.565.516.409.176.897.32NA7.295.722.862.202.793.193.82NANANA
Contract With Customer Liability Current 40.8049.5056.23NANANA57.93NANANA55.37NANANANANANANANANANANA

    2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31
Other Liabilities Noncurrent 0.420.550.670.710.600.700.800.901.001.400.30NA0.300.600.650.600.600.900.90NANANA
Operating Lease Liability Noncurrent 107.13108.99111.01112.72107.32104.06105.4887.1788.1177.3577.83NA6.436.847.226.767.78NA8.89NANANA

    2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31
Stockholders Equity 473.98513.71548.56563.58611.23590.26447.89463.11493.06530.67557.07NA605.75631.77624.01630.88296.12295.52-93.36NANANA
Stockholders Equity Including Portion Attributable To Noncontrolling Interest 473.98513.71548.56563.58611.23590.26447.90463.12493.07530.67557.09579.82605.77631.78624.02630.89296.15295.55-93.32-87.25-76.55-76.66
Additional Paid In Capital Common Stock 920.62906.19885.97871.10856.91840.45828.70818.01807.83797.00786.96NA769.20760.57752.56748.12417.03414.2511.65NANANA
Retained Earnings Accumulated Deficit -447.19-393.14-338.42-307.75-245.72-250.00-379.14-351.93-312.08-264.39-229.95NA-164.23-129.59-129.56-118.42-122.27-118.92-105.10NANANA
Accumulated Other Comprehensive Income Loss Net Of Tax -0.18-0.070.28-0.49-0.68-0.90-2.38-3.69-3.40-2.66-0.65NA0.080.080.320.480.73-0.440.02NANANA
Stock Issued During Period Value New Issues 1.067.62NANANANANANANANANANANANANA325.60NA209.63NANANANA
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 12.8112.22NA12.6511.7710.88NA9.8610.439.13NA7.657.024.37NA3.042.731.77NA0.560.530.52

    2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31
Net Cash Provided By Used In Operating Activities -53.72-39.28-37.26-49.94-18.44-31.09-24.94-30.36-24.66-39.72-19.74-10.64-29.37-10.9243.62-12.03-9.05-5.78-11.27-5.93-4.24-4.62
Net Cash Provided By Used In Investing Activities 29.585.08-59.6113.2067.24172.2011.567.8434.3236.30-22.0952.3814.81-61.91-53.24-215.98-24.59-87.916.38-5.66-38.49-16.08
Net Cash Provided By Used In Financing Activities 1.618.012.331.334.520.870.480.320.400.911.221.441.643.661.43328.12-0.73212.45-1.720.2325.015.17

    2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31
Net Cash Provided By Used In Operating Activities -53.72-39.28-37.26-49.94-18.44-31.09-24.94-30.36-24.66-39.72-19.74-10.64-29.37-10.9243.62-12.03-9.05-5.78-11.27-5.93-4.24-4.62
Net Income Loss -54.05-54.72-30.67-62.024.28129.14-27.21-39.85-47.69-34.44-30.71-35.01-34.64-0.03-11.143.85-3.35-13.83-6.77-11.51-0.50-5.79
Profit Loss -54.05-54.72-30.67-62.024.28129.14-27.21-39.86-47.67-34.45-30.71-35.01-34.97-0.52-11.593.29-4.07-14.27-7.14-11.96-0.73-5.85
Depreciation Depletion And Amortization 1.401.441.351.271.171.761.141.111.130.970.650.580.730.89NANA0.880.88NANANANA
Increase Decrease In Accounts Receivable -7.99-46.1546.1110.23-37.04-9.2632.374.82-10.55-2.9420.39-10.0110.09-20.1519.13-1.56-2.42-2.406.80-1.530.83-1.06
Increase Decrease In Accounts Payable -1.79-7.156.580.55-2.282.47-1.425.54-4.271.33-0.182.26-1.26-1.233.63-0.74-0.112.11-3.623.20-0.911.03
Share Based Compensation 12.8112.2212.5312.6511.7710.8810.219.8610.439.137.467.657.024.373.003.042.731.770.580.560.530.52

    2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31
Net Cash Provided By Used In Investing Activities 29.585.08-59.6113.2067.24172.2011.567.8434.3236.30-22.0952.3814.81-61.91-53.24-215.98-24.59-87.916.38-5.66-38.49-16.08
Payments To Acquire Property Plant And Equipment 1.004.092.484.922.433.581.353.001.971.700.962.782.910.510.890.330.480.840.160.290.331.06

    2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31
Net Cash Provided By Used In Financing Activities 1.618.012.331.334.520.870.480.320.400.911.221.441.643.661.43328.12-0.73212.45-1.720.2325.015.17

    2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31
Revenues 47.3336.6074.1342.5735.1964.7856.8436.9838.4748.6646.1729.8529.7832.1333.0325.8023.0926.1725.8319.9619.0120.74
Revenue From Contract With Customer Excluding Assessed Tax 47.3336.6074.1342.5735.1964.7856.8436.9838.4748.6646.1729.8529.7832.1333.0325.8023.0926.1725.8319.9619.0120.74
Operating, Drug Discovery NA3.185.4713.665.8432.579.0212.318.4615.587.615.575.735.798.072.942.192.368.303.844.532.14
Operating, Software NA33.4168.6628.9029.3532.2147.8224.6730.0133.0838.5624.2824.0526.3424.9622.8620.9023.8117.5316.1214.4818.61
Bill And Melinda Gates Foundation Trust, Drug Discovery Services, Related Party 0.420.49NANA0.600.77NANANANANANANANANANANANANANANANA
Bill And Melinda Gates Foundation Trust, S W Services, Related Party 0.060.01NANA0.090.03NANANANANANANANANANANANANANANANA
Bristol Myers Squibb, Collaboration And License Agreement 7.501.50NANA0.7028.10NANANANANANANANANANANANANANANANA
Drug Discovery 11.933.185.4713.665.8432.579.0212.318.4615.587.615.575.735.798.072.942.192.368.303.844.532.14
Hosted Software 8.097.186.015.464.454.454.123.913.603.253.092.682.702.602.372.372.312.131.931.861.911.71
On Premise Software 18.7617.6253.9513.8116.8119.9433.6312.5816.5921.6927.3015.5014.4517.3616.5415.0611.1115.6010.7210.308.6013.02
Professional Services 2.722.733.002.082.212.074.813.113.873.413.571.701.722.282.201.892.932.541.690.931.121.28
Revenue From Contract With Customer Before Contribution 35.4033.41NA27.1029.3532.21NA24.6729.01NANA24.2823.05NA24.9622.8619.90NA17.5316.1214.48NA
Software Products And Services 35.4033.4168.6628.9029.3532.2147.8224.6730.0133.0838.5624.2824.0526.3424.9622.8620.9023.8117.5316.1214.4818.61
Maintenance 5.845.895.695.755.885.755.255.064.954.734.614.404.184.113.843.543.553.543.183.022.852.59
Bill And Melinda Gates Foundation Trust, Related Party NANA0.070.060.09NA0.050.120.01NANANANANANANANANANANANANA
Structure Therapeutics, Related Party NANA0.210.060.07NANA0.070.07NANANANANANANANANANANANANA
Drug Discovery 11.93NANANA5.84NANANANANANANANANANANANANANANANANA
Software 35.40NANANA29.35NANANANANANANANANANANANANANANANANA
US 30.7023.3054.5333.1323.9650.3438.7127.4727.1030.2731.9921.8219.6816.9116.3417.7713.1413.4915.6611.1510.949.87
APAC 8.715.505.695.576.247.076.174.892.97NANANANANANANANANANANANANA
EMEA 7.807.2013.723.764.836.8311.764.425.11NANANANANANANANANANANANANA
Non Us 0.120.600.190.120.163.43-9.863.653.294.192.532.542.953.142.121.852.032.441.731.191.361.76

Plots across concepts


IncomeStatement
Comprehensive Income Net Of Tax
Expenses
Income Tax Expense Benefit
Balance Sheet
Goodwill
Assets
Goodwill
Current Assets
Accounts Receivable Net Current
NonCurrent Assets
Other Assets Noncurrent
Liabilities
Liabilities Current
Current Liabilities
Accounts Payable Current
Stockholders Equity
Retained Earnings Accumulated Deficit
CashFlow
Net Income Loss
NetCashProvidedByUsedInOperatingActivities
Net Income Loss
NetCashProvidedByUsedInInvestingActivities
Payments To Acquire Property Plant And Equipment
Shares
Weighted Average Number Of Diluted Shares Outstanding
OperatingLeaseLiability
Operating Lease Liability Current
NonoperatingIncomeExpense
Nonoperating Income Expense
AccountsReceivable
Allowance For Doubtful Accounts Receivable Current

Line plots across dimensions of each concept